Status:
COMPLETED
The dıagnostıc Value of Serum autotaxın Level ın Colorectal Cancer
Lead Sponsor:
Diskapi Yildirim Beyazit Education and Research Hospital
Conditions:
Colo-rectal Cancer
Eligibility:
MALE
18+ years
Brief Summary
Colorectal cancer is one of the most common causes of cancer-related death. Early diagnosis is extremely important in terms of treatment and mortality. In this study, we investigated the diagnostic va...
Detailed Description
Colorectal cancer (CRC) is the third most common type of cancer worldwide. Among the causes of death due to cancer; it is the second most common among both genders with a rate of 9.2% after lung cance...
Eligibility Criteria
Inclusion
- stage 1-3 colorectal cancer
- control group included healthy volunteers who had undergone screening colonoscopy within the last month , had no pathology,
Exclusion
- metastatic disease,
- received neoadjuvant therapy
- received systemic chemoradiotherapy
- had any known systemic inflammatory or autoimmune disease
- had a with another concurrent malignancy
- had been previously diagnosed and treated for another malignancy
Key Trial Info
Start Date :
December 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 25 2021
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT06091592
Start Date
December 30 2020
End Date
December 25 2021
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dışkapı Yıldırım Beyazıt training and research hospital
Ankara, Turkey (Türkiye), 06610